sub maximal

Related by string. submaximal * Subs . subs . subd . Suber . SUB . SUBS . sub. . Sub . Subd : #:# SUB OUT . Merger Sub Inc. . Sub Pop . sub inspector . #:# SUB IN . sub par . sub Saharan Africans . Sub Inspector . Sub Sahara Africa / Maximal : maximal lifespan . maximal oxygen uptake . maximal tolerated . maximal aerobic capacity . maximal plasma . maximal aerobic . maximal doses . maximal oxygen consumption * *

Related by context. Frequent words. (Click for all words.) 62 pharmacodynamic effects 62 serum phosphorus 62 contractility 61 clinically meaningful improvement 61 ventilatory 61 dobutamine 60 mL kg 60 QTc 60 lytic 60 fraction LVEF 60 pharmacokinetic parameters 60 erythrocyte sedimentation rate 60 parathyroid hormone PTH 60 metabolic parameters 59 CIMZIA TM 59 catecholamine 59 dose titration 59 antiangiogenic 59 μmol L 59 mucosal healing 59 glycemia 59 teriflunomide 59 infarct size 59 maximal 59 irbesartan 59 HbA 1c 58 GHRH 58 serum concentrations 58 glucose homeostasis 58 experimentally induced 58 liposomal formulation 58 analgesic efficacy 58 platelet reactivity 58 mg kg dose 58 Traficet EN 58 fluence 58 IU ml 58 bronchodilation 58 μg kg 58 serum testosterone 57 alteplase 57 platelet inhibition 57 fibrinolysis 57 prospectively defined 57 apolipoprotein B 57 achieved statistical significance 57 fat oxidation 57 Natalizumab 57 IFN alpha 57 OGTT 57 murine model 57 HPA axis 57 intracoronary 57 coadministration 57 dosing interval 57 lanthanum carbonate 57 IGFBP 3 57 posttreatment 57 catabolism 56 alagebrium 56 T2DM 56 rhGH 56 partial agonist 56 GFT# 56 contractile 56 corticosteroid therapy 56 platelet activation 56 intravitreal injections 56 ischaemia 56 Cmax 56 CI -#.# 56 monomeric 56 statistically significant p = 56 Secondary endpoints include 56 lispro 56 efficacy endpoint 56 CK MB 56 lavage 56 EVIZON 56 ARIKACE 56 tumor resection 56 CTLs 56 VO2max 56 ketorolac 56 APOPTONE 56 intramuscularly 56 creatine kinase 56 cerebral ischemia 56 nephrotoxicity 56 skeletal muscle mass 56 exhaled nitric oxide 56 Secondary endpoints included 56 HbA1C 56 nociceptive 55 hematologic toxicity 55 paramagnetic 55 hypoxemia 55 CTA# 55 claudication 55 glycated hemoglobin 55 ACTH

Back to home page